Equities

Bonesupport Holding AB

Bonesupport Holding AB

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)370.20
  • Today's Change10.20 / 2.83%
  • Shares traded376.46k
  • 1 Year change+124.36%
  • Beta0.8967
Data delayed at least 15 minutes, as of Nov 25 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue591329213
OPERATING EXPENSES
Cost of revenue total503123
Selling, general and admin. expenses, total462312222
Depreciation/amortization------
Unusual expense(income)--0(0.35)
Other operating expenses, total40406.00
Total operating expense577393294
Operating income14(65)(81)
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes16(65)(82)
Provision for income taxes(229)3.473.69
Net income after taxes245(68)(86)
Minority interest------
Net income before extra. Items245(68)(86)
Total extraordinary items------
Net income245(68)(86)
Inc.avail. to common excl. extra. Items245(68)(86)
Inc.avail. to common incl. extra. Items245(68)(86)
EPS RECONCILIATION
Basic/primary weighted average shares666464
Basic/primary eps excl. extra items3.74(1.06)(1.34)
Basic/primary eps incl. extra items3.74(1.06)(1.34)
Dilution adjustment------
Diluted weighted average shares666464
Diluted eps excl. extra items3.74(1.06)(1.34)
Diluted eps incl. extra items3.74(1.06)(1.34)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue000
Gross dividend - common stock00--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental3.120.971.27
SUPPLEMENTAL INCOME
Depreciation, supplemental8.668.088.63
Total special items--0(0.35)
NORMALISED INCOME
Normalized income before taxes16(65)(82)
Effect of special items on income taxes--0(0.12)
Income tax excluding impact of special items(229)3.473.57
Normalized income after tax245(68)(86)
Normalized income avail. to common245(68)(86)
Basic normalized EPS3.74(1.06)(1.34)
Diluted normalized EPS3.74(1.06)(1.34)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.